These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 24553726)
1. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients. Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726 [TBL] [Abstract][Full Text] [Related]
2. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea. Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161 [TBL] [Abstract][Full Text] [Related]
3. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients. Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314 [TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy. Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411 [TBL] [Abstract][Full Text] [Related]
5. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331 [TBL] [Abstract][Full Text] [Related]
6. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121 [TBL] [Abstract][Full Text] [Related]
7. Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study. Saito K; Mukasa A; Narita Y; Tabei Y; Shinoura N; Shibui S; Saito N Neurol Med Chir (Tokyo); 2014; 54(4):272-9. PubMed ID: 24257502 [TBL] [Abstract][Full Text] [Related]
8. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas. Rhee DJ; Kong DS; Kim WS; Park KB; Lee JI; Suh YL; Song SY; Kim ST; Lim DH; Park K; Kim JH; Nam DH Clin Neurol Neurosurg; 2009 Nov; 111(9):748-51. PubMed ID: 19716649 [TBL] [Abstract][Full Text] [Related]
11. A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime. Teo M; Martin S; Owusu-Agyemang K; Nowicki S; Clark B; Mackinnon M; Stewart W; Paul J; St George J Br J Neurosurg; 2014 Jun; 28(3):351-5. PubMed ID: 24111708 [TBL] [Abstract][Full Text] [Related]
12. Outcome of salvage treatment for recurrent glioblastoma. Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963 [TBL] [Abstract][Full Text] [Related]
13. Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaging. Kim JH; Choi SH; Ryoo I; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Sohn CH; Park SH; Kim IH PLoS One; 2014; 9(11):e113587. PubMed ID: 25419975 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Niyazi M; Schwarz SB; Suchorska B; Belka C Strahlenther Onkol; 2012 Feb; 188(2):154-9. PubMed ID: 22231634 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma. Zhang C; Wang X; Hao S; Su Z; Zhang P; Li Y; Song G; Yu L; Wang J; Ji N; Xie J; Gao Z World Neurosurg; 2016 Nov; 95():77-84. PubMed ID: 27485530 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide. Younis SG; Khedr RA; El-Shorbagy SH J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634 [TBL] [Abstract][Full Text] [Related]
17. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R; Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067 [TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
19. Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma? Goda JS; Lewis S; Agarwal A; Epari S; Churi S; Padmavati A; Gupta T; Shetty P; Moiyadi A; Jalali R Clin Neurol Neurosurg; 2015 Aug; 135():46-53. PubMed ID: 26038275 [TBL] [Abstract][Full Text] [Related]